Cargando…
1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506387/ http://dx.doi.org/10.1016/j.annonc.2020.08.1707 |
| _version_ | 1783585006828912640 |
|---|---|
| author | Banna, G.L. Cantale, O. Friedlaender, A. Addeo, A. |
| author_facet | Banna, G.L. Cantale, O. Friedlaender, A. Addeo, A. |
| author_sort | Banna, G.L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506387 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75063872020-09-23 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy Banna, G.L. Cantale, O. Friedlaender, A. Addeo, A. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506387/ http://dx.doi.org/10.1016/j.annonc.2020.08.1707 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Banna, G.L. Cantale, O. Friedlaender, A. Addeo, A. 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title | 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title_full | 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title_fullStr | 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title_full_unstemmed | 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title_short | 1393P Risk of SARS-CoV2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| title_sort | 1393p risk of sars-cov2-related mortality in non-small cell lung cancer patients treated with first-line immune-oncology alone or in combination with chemotherapy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506387/ http://dx.doi.org/10.1016/j.annonc.2020.08.1707 |
| work_keys_str_mv | AT bannagl 1393priskofsarscov2relatedmortalityinnonsmallcelllungcancerpatientstreatedwithfirstlineimmuneoncologyaloneorincombinationwithchemotherapy AT cantaleo 1393priskofsarscov2relatedmortalityinnonsmallcelllungcancerpatientstreatedwithfirstlineimmuneoncologyaloneorincombinationwithchemotherapy AT friedlaendera 1393priskofsarscov2relatedmortalityinnonsmallcelllungcancerpatientstreatedwithfirstlineimmuneoncologyaloneorincombinationwithchemotherapy AT addeoa 1393priskofsarscov2relatedmortalityinnonsmallcelllungcancerpatientstreatedwithfirstlineimmuneoncologyaloneorincombinationwithchemotherapy |